Roche arthritis drug cuts deaths in hospitalized COVID-19 patients, study suggests


Roche’s arthritis drug tocilizumab cuts the risk of death among patients hospitalized with severe COVID-19, also shortening the time to recovery and reducing the need for mechanical ventilation, a large clinical trial suggests.

Share this post

Leave a Reply

Your email address will not be published. Required fields are marked *